Compared with the healthy samples, the expression levels of FOSB, GPAT3, and RGCC were significantly downregulated in the NAFLD samples (Fig. 2D, E, F); whereas the expression level of RNF43 was significantly upregulated in the NAFLD samples (Fig. 2G). This evidence concerns the gene GPAT3 and metabolic dysfunction-associated steatotic liver disease.